Mark Marriott

2.4k total citations
28 papers, 758 citations indexed

About

Mark Marriott is a scholar working on Pathology and Forensic Medicine, Neurology and Immunology. According to data from OpenAlex, Mark Marriott has authored 28 papers receiving a total of 758 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Pathology and Forensic Medicine, 9 papers in Neurology and 6 papers in Immunology. Recurrent topics in Mark Marriott's work include Multiple Sclerosis Research Studies (13 papers), Peripheral Neuropathies and Disorders (5 papers) and Reproductive System and Pregnancy (4 papers). Mark Marriott is often cited by papers focused on Multiple Sclerosis Research Studies (13 papers), Peripheral Neuropathies and Disorders (5 papers) and Reproductive System and Pregnancy (4 papers). Mark Marriott collaborates with scholars based in Australia, United States and France. Mark Marriott's co-authors include Trevor J. Kilpatrick, Helmut Butzkueven, Scott Kolbe, Ben Emery, Gary F. Egan, Anneke van der Walt, Michele D. Binder, Holly S. Cate, Peter Mitchell and Dennis Kemper and has published in prestigious journals such as Proceedings of the National Academy of Sciences, PLoS ONE and Neurology.

In The Last Decade

Mark Marriott

27 papers receiving 744 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mark Marriott Australia 13 296 207 184 133 130 28 758
Erik Wallstroem United States 8 636 2.1× 276 1.3× 243 1.3× 217 1.6× 231 1.8× 20 1.0k
Eva Strijbis Netherlands 17 674 2.3× 161 0.8× 88 0.5× 231 1.7× 145 1.1× 98 1.0k
Reem F. Bunyan Saudi Arabia 8 760 2.6× 224 1.1× 123 0.7× 273 2.1× 152 1.2× 23 1.0k
Alicja Kalinowska Poland 16 329 1.1× 138 0.7× 55 0.3× 221 1.7× 170 1.3× 59 807
Wolfgang Brueck Germany 10 222 0.8× 276 1.3× 70 0.4× 88 0.7× 165 1.3× 13 634
Mariola Matysiak Poland 15 251 0.8× 222 1.1× 121 0.7× 76 0.6× 265 2.0× 34 825
Doralina Guimarães Brum Brazil 16 419 1.4× 159 0.8× 56 0.3× 179 1.3× 185 1.4× 26 703
Hanane Touil Canada 11 477 1.6× 570 2.8× 95 0.5× 173 1.3× 204 1.6× 18 1.1k
Etsuji Saji Japan 7 390 1.3× 210 1.0× 53 0.3× 185 1.4× 128 1.0× 15 712
George J. Hutton United States 14 619 2.1× 201 1.0× 64 0.3× 213 1.6× 116 0.9× 46 865

Countries citing papers authored by Mark Marriott

Since Specialization
Citations

This map shows the geographic impact of Mark Marriott's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark Marriott with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark Marriott more than expected).

Fields of papers citing papers by Mark Marriott

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark Marriott. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark Marriott. The network helps show where Mark Marriott may publish in the future.

Co-authorship network of co-authors of Mark Marriott

This figure shows the co-authorship network connecting the top 25 collaborators of Mark Marriott. A scholar is included among the top collaborators of Mark Marriott based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark Marriott. Mark Marriott is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wesselingh, Robb, Wei Zhen Yeh, Olga Skibina, et al.. (2023). Neutropaenia complications from Ocrelizumab and Rituximab treatment. Multiple Sclerosis and Related Disorders. 81. 105147–105147. 8 indexed citations
2.
Li, Vivien, Izanne Roos, Mastura Monif, et al.. (2022). Impact of telehealth on health care in a multiple sclerosis outpatient clinic during the COVID-19 pandemic. Multiple Sclerosis and Related Disorders. 63. 103913–103913. 9 indexed citations
3.
Marriott, Mark, et al.. (2022). Failure of alemtuzumab therapy in three patients with MOG antibody associated disease. BMC Neurology. 22(1). 84–84. 5 indexed citations
4.
Sharmin, Sifat, Vivien Li, Ai‐Lan Nguyen, et al.. (2021). Predicting Infection Risk in Multiple Sclerosis Patients Treated with Ocrelizumab: A Retrospective Cohort Study. CNS Drugs. 35(8). 907–918. 30 indexed citations
5.
Li, Vivien, Ai‐Lan Nguyen, Izanne Roos, et al.. (2020). Evaluating the perspective of patients with MS and related conditions on their DMT in relation to the COVID-19 pandemic in one MS centre in Australia. Multiple Sclerosis and Related Disorders. 46. 102516–102516. 8 indexed citations
6.
7.
Ramachandran, Prashanth, Eddie Chan, Michael T. C. Poon, et al.. (2017). Adult food borne botulism in Australia: The only 2 cases from the last 15 years. Journal of Clinical Neuroscience. 41. 86–87. 1 indexed citations
8.
Maingard, Julian, Lauren Giles, Mark Marriott, & Pramit M. Phal. (2015). Cervical CT scan-guided epidural blood patches for spontaneous intracranial hypotension. Journal of Clinical Neuroscience. 22(12). 1973–1976. 2 indexed citations
9.
Steinhubl, Steven R., Mark Marriott, & Stephan Wegerich. (2015). Remote Sensing of Vital Signs: A Wearable, Wireless “Band-Aid” Sensor With Personalized Analytics for Improved Ebola Patient Care and Worker Safety. Global Health Science and Practice. 3(3). 516–519. 16 indexed citations
10.
Walt, Anneke van der, Scott Kolbe, Alexander Klistorner, et al.. (2013). Optic Nerve Diffusion Tensor Imaging after Acute Optic Neuritis Predicts Axonal and Visual Outcomes. PLoS ONE. 8(12). e83825–e83825. 41 indexed citations
11.
Walt, Anneke van der, Scott Kolbe, Neil Shuey, et al.. (2012). The temporal profile of optic nerve DTI measures and RNFL thickness in the first year after acute optic neuritis. Multiple Sclerosis Journal. 18(5). 700–700. 1 indexed citations
12.
Walt, Anneke van der, Helmut Butzkueven, Scott Kolbe, et al.. (2010). Neuroprotection in multiple sclerosis: A therapeutic challenge for the next decade. Pharmacology & Therapeutics. 126(1). 82–93. 47 indexed citations
13.
Stankovich, Jim, Helmut Butzkueven, Mark Marriott, et al.. (2009). HLA‐DRB1 associations with disease susceptibility and clinical course in Australians with multiple sclerosis. Tissue Antigens. 74(1). 17–21. 3 indexed citations
14.
Marriott, Mark, Ben Emery, Holly S. Cate, et al.. (2008). Leukemia inhibitory factor signaling modulates both central nervous system demyelination and myelin repair. Glia. 56(6). 686–698. 68 indexed citations
15.
Rubio, Justin P., Jim Stankovich, Judith Field, et al.. (2008). Replication of KIAA0350, IL2RA, RPL5 and CD58 as multiple sclerosis susceptibility genes in Australians. Genes and Immunity. 9(7). 624–630. 97 indexed citations
16.
Wu, Qizhu, Qing Yang, Holly S. Cate, et al.. (2007). MRI identification of the rostral‐caudal pattern of pathology within the corpus callosum in the cuprizone mouse model. Journal of Magnetic Resonance Imaging. 27(3). 446–453. 72 indexed citations
17.
Rubio, Justin P., Niall Tubridy, Melanie Bahlo, et al.. (2004). Extended haplotype analysis in the HLA complex reveals an increased frequency of the HFE-C282Y mutation in individuals with multiple sclerosis. Human Genetics. 114(6). 573–580. 41 indexed citations
18.
19.
Kilpatrick, Trevor J., Helmut Butzkueven, Ben Emery, et al.. (2004). Neuroglial responses to CNS injury: prospects for novel therapeutics. Expert Review of Neurotherapeutics. 4(5). 869–878. 3 indexed citations
20.
Marriott, Mark, Richard Macdonell, & Paul McCrory. (2002). Flail arms in a parachutist: an unusual presentation of hereditary neuropathy with liability to pressure palsies. British Journal of Sports Medicine. 36(6). 465–466. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Erik Wallstroem Breakdown of academic impact, for papers by Eva Strijbis Breakdown of academic impact, for papers by Reem F. Bunyan Breakdown of academic impact, for papers by Alicja Kalinowska Breakdown of academic impact, for papers by Wolfgang Brueck Breakdown of academic impact, for papers by Mariola Matysiak Breakdown of academic impact, for papers by Doralina Guimarães Brum Breakdown of academic impact, for papers by Hanane Touil Breakdown of academic impact, for papers by Etsuji Saji Breakdown of academic impact, for papers by George J. Hutton
Rankless by CCL
2026